Jeremy G. Chadwick's most recent trade in Kymera Therapeutics Inc was a trade of 2,575 Common Stock done at an average price of $29.3 . Disclosure was reported to the exchange on May 23, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kymera Therapeutics Inc | Jeremy G. Chadwick | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 29.30 per share. | 23 May 2025 | 2,575 | 66,420 | - | 29.3 | 75,436 | Common Stock |
| Kymera Therapeutics Inc | Jeremy G. Chadwick | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Kymera Therapeutics Inc | Jeremy G. Chadwick | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 25,000 | 69,183 | - | 0 | Common Stock | |
| Kymera Therapeutics Inc | Jeremy G. Chadwick | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 30.33 per share. | 03 Mar 2025 | 1,131 | 68,052 | - | 30.3 | 34,300 | Common Stock |
| Kymera Therapeutics Inc | Jeremy G. Chadwick | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 31.00 per share. | 03 Mar 2025 | 252 | 67,800 | - | 31.0 | 7,813 | Common Stock |
| Kymera Therapeutics Inc | Jeremy G. Chadwick | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 34.99 per share. | 23 May 2024 | 2,575 | 44,183 | - | 35.0 | 90,105 | Common Stock |
| Kymera Therapeutics Inc | Jeremy G. Chadwick | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 80,548 | 80,548 | - | - | Stock Option (Right to Buy) | |
| Kymera Therapeutics Inc | Jeremy G. Chadwick | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 13,425 | 46,758 | - | 0 | Common Stock | |
| Kymera Therapeutics Inc | Jeremy G. Chadwick | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2023 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Kymera Therapeutics Inc | Jeremy G. Chadwick | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2023 | 33,333 | 33,333 | - | 0 | Common Stock |